Lisdexamfetamine Completed Phase 4 Trials for Attention Deficit Hyperactivity Disorder (ADHD) Basic Science

IndicationsStatusPurposePhase
CompletedBasic Science4
clinicaltrials.gov IdentifierTitleDrugs
NCT01924429Neurobiological Basis of Response to Vyvanse in Adults With ADHD: an fMRI Study of Brain Activation